Glycoprotein 330/Megalin (LRP-2) Has Low Prevalence as mRNA and Protein in Brain Microvessels and Choroid Plexus
- 1 May 1999
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 157 (1) , 194-201
- https://doi.org/10.1006/exnr.1999.7052
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Nascent Astrocyte Particles Differ from Lipoproteins in CSFJournal of Neurochemistry, 1998
- A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain BarrierThe Journal of cell biology, 1997
- Calcium cages, acid baths and recycling receptorsNature, 1997
- Interaction of Apolipoprotein J-Amyloid β-Peptide Complex with Low Density Lipoprotein Receptor-related Protein-2/MegalinJournal of Biological Chemistry, 1997
- Expression of the Very Low-Density Lipoprotein Receptor (VLDL-r), an Apolipoprotein-E Receptor, in the Central Nervous System and in Alzheimerʼs DiseaseJournal of Neuropathology and Experimental Neurology, 1996
- The unfolding story of megalin (gp330): now recognized as a drug receptor.Journal of Clinical Investigation, 1995
- The Heymann nephritis antigenic complexJournal of the American Society of Nephrology, 1995
- Clusterin: the intriguing guises of a widely expressed glycoproteinTrends in Biochemical Sciences, 1992
- Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis ratsThe Journal of Experimental Medicine, 1983
- Significance of rare mRNA sequences in liverArchives of Biochemistry and Biophysics, 1977